Philadelphia Eagles quarterback Jalen Hurts is expected to miss the rest of the season after being diagnosed with blood clots, according to a source cited by the Associated Press — a development that, if confirmed, would remove one of the NFL’s most important players from the field and reshape the Eagles’ campaign at a stroke. The team has not yet laid out a full public timeline, and details of Hurts’ treatment and condition remain limited.
A Report That Changes Philadelphia’s Season
Blood clots are a serious medical condition for any athlete, and particularly for a quarterback whose game depends on mobility, absorbing contact and travelling with the team through a long season. Treatment commonly involves blood-thinning medication, which is fundamentally incompatible with a sport built on collisions: a player on anticoagulants faces elevated risks from the hits that are unavoidable in professional football. That medical reality is why reports of this kind usually point toward an extended absence rather than a quick return.
Hurts has been the engine of Philadelphia’s offence — a dual-threat quarterback whose running reshapes defensive game plans and whose composure in big moments defined the Eagles’ recent identity. Losing him for the remainder of the season would not be a routine injury absence. It would force the franchise to re-plan its offence, its play-calling and, frankly, its ambitions, around whoever takes the snaps next.
What Blood Clots Mean for an Athlete
Clots can form in the legs — deep vein thrombosis — or travel to the lungs, a pulmonary embolism, which can be life-threatening. Athletes are not immune: long flights, dehydration, injuries and surgeries can all raise risk, and several prominent players across American sports have faced the same diagnosis. In the best-known cases, recovery has taken months, and returns have been carefully staged with medical supervision at every step.
Why a quick return is unlikely
Even when a player feels well, the treatment clock governs the comeback. Blood thinners are typically prescribed for a minimum period measured in months, and clearing a contact athlete requires the medication course to end and specialists to be satisfied the underlying risk has passed. Eagles fans looking for precedents will find them sobering: seasons have ended over this diagnosis before, which is precisely why the AP report frames Hurts’ absence as season-long rather than week-to-week. Official team and league updates will appear through channels including the NFL’s official site as the situation develops.
The Backup Question in Philadelphia
Attention now turns to the Eagles’ quarterback room. A backup stepping in at midseason inherits an offence designed around Hurts’ specific gifts — designed runs, run-pass options and a deep-ball threat built on defensive hesitation. No understudy replicates that skill set, so the coaching staff’s real task is redesign, not replacement: lean more heavily on the running backs and offensive line, shorten the passing game, and protect a quarterback whose strengths are different.
Philadelphia’s roster was built to contend, which cuts both ways. The talent around the quarterback position — receivers, line, a defence expected to hold up its end — gives a stand-in a better platform than most. But contending teams also face the standings reality that every week with an adjusted offence is a week rivals can gain ground. Readers can follow continuing coverage on latestroyalnews.com as the Eagles confirm their plans.
Reaction From Around the League
News of a star quarterback’s serious health issue tends to travel fast and land heavily, and the first reaction across the league is usually concern for the player rather than the standings. Hurts is 27, in his prime, and has spoken often about durability and preparation as points of pride. A diagnosis that sidelines him through no fault of training or toughness is the kind of randomness that players across team lines recognise and respect.
The story was broken by the Associated Press, whose sourcing on league matters is closely watched; the report’s careful wording — expected to miss the rest of the season — leaves room for medical developments, but not much room for optimism about a playoff return. Until the Eagles speak in detail, that framing is likely to stand as the working assumption inside the building and across the fanbase.
The Schedule Will Not Wait
The NFL calendar offers no sympathy and no pause button. Philadelphia’s upcoming opponents will prepare for a different offence, testing the backup early with pressure packages designed to find out how much of the playbook the Eagles still trust. Division games, in particular, become treacherous: rivals who know Philadelphia best will happily turn the season’s remaining weeks into a referendum on the team’s depth. How the Eagles handle the first fortnight without Hurts — protecting the ball, winning field position, leaning on their defence — will likely determine whether this becomes a story of a season rescued or a season quietly conceded.
What Happens Next
In the coming days, the key questions are medical before they are tactical. Has the clot’s location and severity been fully assessed? Is surgery or only medication involved? And what does the treatment timeline mean not just for this season, but for Hurts’ long-term career? On the current reporting, his health outlook — with prompt diagnosis and treatment — is the genuinely important positive, even on a bleak day for the franchise.
For Philadelphia, the season now becomes a test of organisational depth: coaching adaptability, roster construction and the resilience of a locker room that has handled adversity before. For Hurts, the task is simpler and harder — recover fully, on medicine’s timetable, not football’s. The Eagles’ year will be defined by how they play without him; his career, everyone around the team will hope, will not be.
